Expansion Opportunity CenExel CBH is part of a growing clinical research network with recent leadership hires and facility expansions across the CNS space. This presents opportunities to cross-sell integrated site management, patient recruitment, and CNS trial execution services to adjacent CenExel locations and new programs.

CNS Focus Advantage Specialization in CNS disorders with a large patient referral network and 300+ trials completed positions CenExel CBH as a trusted partner for CNS studies, enabling faster patient enrollment, study feasibility input, and high-quality data for depression, schizophrenia, and bipolar disorder trials.

Strategic Partnerships Strong ties to Mid-Atlantic referral sources and proximity to Johns Hopkins University create avenues for partnerships with academic medical centers, hospital systems, and patient advocacy groups to facilitate site referrals and collaborative research programs.

Operational Scale A dedicated 40-bed clinical research unit and inpatient capabilities demonstrate operational vigor and capacity for complex inpatient CNS trials, enabling opportunities to pitch full-service trial management, CRU operations, and patient retention strategies to sponsors.

Financial Synergies Recent C-suite appointments and visible investment in facilities signal potential for sponsors seeking financially stable, growth-oriented sites; present value propositions around cost efficiency, risk mitigation, and expanded trial scope within a reputable CNS-focused network.